Back to Search Start Over

Origin of Residual Tumor Masses in BRCA1/2-Driven Ovarian Carcinomas Treated by Neoadjuvant Chemotherapy: Selection of Preexisting BRCA1/2-Proficient Tumor Cells but Not the Gain of Second ORF-Restoring Mutation.

Details

Language :
English
ISSN :
10152008
Volume :
91
Issue :
2
Database :
Complementary Index
Journal :
Pathobiology
Publication Type :
Academic Journal
Accession number :
176448665
Full Text :
https://doi.org/10.1159/000533591